Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the relationship of incremental doses of NVA237 q.d. and b.i.d. and their effect on trough FEV1 after 28 days of treatment, as defined by the percentage of the maximal effect that each dose achieves in relation to the maximal effect of NVA237. (Trough is defined as the mean of FEV1 measurements at 23 h 15 min and 23 h 45 min post morning dose).
Critère d'inclusion
- Chronic Obstructive Pulmonary Disease (COPD)